Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer

Cancer Chemotherapy and Pharmacology

Volumn 65, Issue 3, 2010, Pages 589-595

  Bae, Woo Kyun ^a   Hwang, Jun Eul ^a   Shim, Hyun Jeong ^a   Cho, Sang Hee ^a,c   Lee, Joon Kyoo ^a   Lim, Sang Chul ^a   Chung, Woong Ki ^a   Chung, Ik Joo ^a,b  

^a Chonnam National University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Chonnam National University Research Institute of Medical Sciences   (South Korea)

Author keywords

Chemoradiotherapy; Docetaxel; Induction chemotherapy; Nasopharyngeal carcinoma

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; CISPLATIN; DOCETAXEL; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; LEVOFLOXACIN; ANTINEOPLASTIC AGENT; TAXOID;

ADULT; ANEMIA; ANOREXIA; ARTICLE; ASTHENIA; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DERMATITIS; DIARRHEA; DRUG DOSE REDUCTION; DRUG SAFETY; ERYTHEMA; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; KIDNEY DISEASE; LUNG METASTASIS; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CANCER; NAUSEA; NEPHROTOXICITY; NEUROPATHY; NEUROTOXICITY; NEUTROPENIA; ODYNOPHAGIA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SKIN ULCER; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING; CANCER STAGING; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; FEASIBILITY STUDY; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NASOPHARYNX TUMOR; PATHOLOGY; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MUCOSITIS; NASOPHARYNGEAL NEOPLASMS; NAUSEA; NEOPLASM STAGING; NEUTROPENIA; TAXOIDS; TREATMENT OUTCOME;

EID: 75549092146     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-1152-0     Document Type: Article

References (27)

1. JC Lin JS Jan CY Hsu WM Liang RS Jiang WY Wang 2003 Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival J Clin Oncol 21 631 637 10.1200/JCO.2003.06.158 12586799 (Pubitemid 46621896)
2. AT Chan PM Teo RK Ngan TW Leung WH Lau B Zee SF Leung FY Cheung W Yeo HH Yiu KH Yu KW Chiu DT Chan T Mok KT Yuen F Mo M Lai WH Kwan P Choi PJ Johnson 2002 Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial J Clin Oncol 20 2038 2044 10.1200/JCO.2002.08.149 1:CAS:528:DC%2BD38XjvVKmsrs%3D 11956263 (Pubitemid 34408793)
3. B Baujat H Audry J Bourhis AT Chan H Onat DT Chua DL Kwong M Al-Sarraf KH Chi M Hareyama SF Leung K Thephamongkhol JP Pignon MAC-NPC Collaborative Group 2006 Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients Int J Radiat Oncol Biol Phys 64 47 56 1:CAS:528:DC%2BD2MXhtlCqur3P 16377415
4. BB Ma AT Chan 2006 Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma Exp Rev Anticancer Ther 6 383 394 10.1586/14737140.6.3.383 1:CAS:528:DC%2BD28XivV2lt7Y%3D (Pubitemid 44192920)
5. M Al-Sarraf M LeBlanc PG Giri KK Fu J Cooper T Vuong AA Forastiere G Adams WA Sakr DE Schuller JF Ensley 1998 Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099 J Clin Oncol 16 1310 1317 1:STN:280:DyaK1c3htFOmtQ%3D%3D 9552031
6. J Wee EH Tan BC Tai HB Wong SS Leong T Tan ET Chua E Yang KM Lee KW Fong HS Tan KS Lee S Loong V Sethi EJ Chua D Machin 2005 Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety J Clin Oncol 23 6730 6738 10.1200/JCO.2005.16.790 1:CAS:528: DC%2BD2MXhtFWqsLfK 16170180 (Pubitemid 46190268)
7. DT Chua J Ma JS Sham HQ Mai DT Choy MH Hong TX Lu HQ Min 2005 Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials J Clin Oncol 23 1118 1124 10.1200/JCO.2005.12.081 1:CAS:528:DC%2BD2MXitl2gtbk%3D 15657403 (Pubitemid 46202267)
8. International Nasopharynx Cancer Study Group: VUMCA I trial 1996 Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or =N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival Int J Radiat Oncol Biol Phys 35 463 469
9. J Ma HQ Mai MH Hong HQ Min ZD Mao NJ Cui TX Lu HY Mo 2001 Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma J Clin Oncol 19 1350 1357 1:CAS:528: DC%2BD3MXit1ert7Y%3D 11230478
10. JL Oh EE Vokes MS Kies BB Mittal ME Witt RR Weichselbaum DJ Haraf 2003 Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer Ann Oncol 14 564 569 10.1093/annonc/mdg163 1:STN:280:DC%2BD3s7jsVSjtg%3D%3D 12649102 (Pubitemid 41295084)
11. AT Chan BB Ma YM Lo SF Leung WH Kwan EP Hui TS Mok M Kam LS Chan SK Chiu KH Yu KY Cheung K Lai M Lai F Mo W Yeo A King PJ Johnson PM Teo B Zee 2004 Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA J Clin Oncol 22 3053 3060 10.1200/JCO.2004.05.178 1:CAS:528:DC%2BD2cXpsVGku7s%3D 15284255 (Pubitemid 41103717)
12. R Hitt A López-Pousa J Martínez-Trufero V Escrig J Carles A Rizo D Isla ME Vega JL Martí F Lobo P Pastor V Valentí J Belón MA Sánchez C Chaib C Pallarés A Antón A Cervantes L Paz-Ares H Cortés-Funes 2005 Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer J Clin Oncol 23 8636 8645 10.1200/JCO.2004.00.1990 16275937 (Pubitemid 46211506)
13. R Hitt L Paz-Ares A Brandáriz D Castellano C Peña JM Millán F Calvo D Ortiz de Urbina E López JJ Alvarez-Vicent H Cortés-Funes 2002 Induction chemotherapy with paclitaxel, cisplatin and 5-fluorouracil for squamous cell carcinoma of the head and neck: long-term results of a phase II trial Ann Oncol 13 1665 1673 10.1093/annonc/mdf268 1:STN:280:DC%2BD38nitVajsw%3D%3D 12377658 (Pubitemid 35331467)
14. G Catimel J Verweij V Mattijssen A Hanauske M Piccart J Wanders H Franklin N Le Bail M Clavel SB Kaye 1994 Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group Ann Oncol 5 533 537 1:STN:280:DyaK2M%2FgtFGrtA%3D%3D 7918125
15. E Au EH Tan PT Ang 1998 Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer Ann Oncol 9 327 329 10.1023/A:1008255220284 1:STN:280:DyaK1c3msV2kug%3D%3D 9602268 (Pubitemid 28186804)
16. EP Hui BB Ma SF Leung AD King F Mo MK Kam BK Yu SK Chiu WH Kwan R Ho I Chan AT Ahuja BC Zee AT Chan 2009 Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma J Clin Oncol 27 242 249 10.1200/JCO.2008.18. 1545 1:CAS:528:DC%2BD1MXhvVKrsbs%3D 19064973
17. W Yeo TW Leung AT Chan SK Chiu P Yu TS Mok PJ Johnson 1998 A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma Eur J Cancer 34 2027 2031 10.1016/S0959-8049(98)00280-9 1:CAS:528:DyaK1MXitVWhtA%3D%3D 10070305 (Pubitemid 28546936)
18. EH Tan KS Khoo J Wee KW Fong KS Lee KM Lee ET Chua T Tan HS Khoo-Tan TL Yang E Au M Tao YK Ong EJ Chua 1999 Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma Ann Oncol 10 235 237 10.1023/A:1008390929826 1:STN:280: DyaK1M7ptlKmtw%3D%3D 10093695 (Pubitemid 29113186)
19. JB Vermorken E Remenar C van Herpen T Gorlia R Mesia M Degardin JS Stewart S Jelic J Betka JH Preiss D van den Weyngaert A Awada D Cupissol HR Kienzer A Rey I Desaunois J Bernier EORTC Lefebvre JL 2497 1/TAX 323 Study Group (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 1695 1704 10.1056/NEJMoa071028
20. MR Posner DM Hershock CR Blajman E Mickiewicz E Winquist V Gorbounova S Tjulandin DM Shin K Cullen TJ Ervin BA Murphy LE Raez RB Cohen M Spaulding RB Tishler B Roth C Viroglio Rdel V Venkatesan I Romanov S Agarwala KW Harter M Dugan A Cmelak AM Markoe PW Read L Steinbrenner AD Colevas CM Norris Jr RI Haddad TAX 324 Study Group 2007 Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 1705 1715 10.1056/NEJMoa070956 1:CAS:528:DC%2BD2sXht1ansLvI 17960013 (Pubitemid 350005152)
21. WI Wei JS Sham 2005 Nasopharyngeal carcinoma Lancet 365 2041 2054 10.1016/S0140-6736(05)66698-6 15950718 (Pubitemid 40812341)
22. M Altun A Fandi O Dupuis E Cvitkovic Z Krajina F Eschwege 1995 Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects Int J Radiat Oncol Biol Phys 32 859 877 1:STN:280: DyaK2MzhtVagtg%3D%3D 7790274
23. D Rischin J Corry J Smith J Stewart P Hughes L Peters 2002 Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation J Clin Oncol 20 1845 1852 10.1200/JCO.2002.07.011 1:CAS:528:DC%2BD38XjtFGqsrg%3D 11919243 (Pubitemid 34273275)
24. A Al-Amro N Al-Rajhi Y Khafaga M Memon A Al-Hebshi A El-Enbabi G El-Husseiny A Radawi A Belal A Allam M El-Sebaie 2005 Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 62 508 513 15890594
25. TK Yau AW Lee DH Wong ES Pang WT Ng RM Yeung IS Soong 2006 Treatment of Stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation: impact of chemotherapy schemes Int J Radiat Oncol Biol Phys 66 1004 1010 1:STN:280:DC%2BD28jgvVCjsg%3D%3D 17145529
26. AW Lee KY Lau WM Hung WT Ng MC Lee CW Choi CC Chan R Tung PT Cheng TK Yau 2008 Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma Radiother Oncol 87 204 210 10.1016/j.radonc.2008.02.003 1:CAS:528:DC%2BD1cXlslyguro%3D 18329742
27. D Ferrari F Chiesa C Codecà L Calabrese BA Jereczek-Fossa D Alterio J Fiore A Luciani I Floriani R Orecchia P Foa 2008 Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study Oncology 74 158 166 10.1159/000151363 1:CAS:528:DC%2BD1cXhtVOnur7F 18714164